Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta blockers in experimental myocardial infarction.

W G Nayler

    Acta Medica Scandinavica. Supplementum
    |January 1, 1981
    PubMed
    Summary

    Beta-blockers like timolol and propranolol can protect heart muscle during ischemia by reducing potassium loss. Pre-treatment with these beta-adrenoceptor antagonists attenuated the increase in extracellular potassium during reperfusion.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Review of preclinical data of calcium channel blockers and atherosclerosis.

    Journal of cardiovascular pharmacology·1999
    Same author

    Third generation calcium entry blockers.

    Blood pressure·1996
    Same author

    New therapeutic trends in calcium antagonism. Are they meaningful?

    American journal of hypertension·1994
    Same author

    End-organ involvement and calcium antagonist therapy: animal studies.

    Journal of cardiovascular pharmacology·1994
    Same author

    Therapeutic approaches to the control of coronary atherosclerosis.

    Basic research in cardiology·1994
    Same author

    The antiatherosclerotic effect of the calcium antagonists and their implications in hypertension.

    American heart journal·1993

    Area of Science:

    • Cardiovascular Pharmacology
    • Myocardial Protection
    • Ischemic Heart Disease Research

    Background:

    • Impaired coronary blood flow leads to myocardial damage, including loss of tension, mitochondrial dysfunction, and ionic imbalance (K+ loss, Na+ and Ca2+ gain).
    • Elevated extracellular potassium during ischemia can trigger cardiac arrhythmias.
    • Beta-adrenoceptor antagonists are theorized to prevent ischemia-induced increases in extracellular potassium.

    Purpose of the Study:

    • To investigate the protective effect of beta-adrenoceptor antagonists against ischemia-induced potassium loss in the myocardium.
    • To determine if pre-treatment or during-reperfusion administration of beta-blockers influences potassium efflux.

    Main Methods:

    • Isolated Sprague-Dawley rat hearts were pre-treated with timolol or propranolol.
    • Hearts underwent 60 minutes of ischemia at 37°C followed by reperfusion.
    • Coronary effluent was collected during the initial 5 minutes of reperfusion to measure potassium (K+) levels.

    Main Results:

    • A significant increase in coronary effluent potassium (K+) was observed during the first 5 minutes of reperfusion (p < 0.001).
    • Prior administration of beta-blockers (timolol or propranolol) significantly attenuated this ischemia-induced K+ loss.
    • Administering beta-blockers during reperfusion did not affect the rate of K+ loss.

    Conclusions:

    • Beta-adrenoceptor antagonists demonstrate a protective effect against myocardial potassium loss during ischemia and reperfusion.
    • Pre-treatment with beta-blockers is crucial for mitigating ischemia-induced extracellular potassium increases.
    • These findings support the therapeutic potential of beta-adrenoceptor antagonists in protecting ischemic heart muscle.

    Related Experiment Videos